Bolt Biotherapeutics (BOLT) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Rodman & Renshaw | Initiated Coverage | Buy | $22.00 | May 29, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | May 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Mar 13, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $7.00 | Oct 20, 2025 |
| Lake Street | Maintained | Buy | $75.00 from $4.00 | Aug 15, 2025 |
| Lake Street | Initiated Coverage | Buy | $4.00 | May 20, 2025 |
| Stifel | Maintained | Hold | $1.00 from $1.25 | May 13, 2025 |
| Stifel | Maintained | Hold | $1.25 from $1.50 | Mar 25, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Mar 25, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Nov 13, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | — | Aug 15, 2024 |
| Stifel | Downgraded | Buy → Hold | $1.50 from $6.00 | May 15, 2024 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | May 15, 2024 |
| Jones Trading | Downgraded | Buy → Hold | — | May 15, 2024 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 from $3.00 | May 15, 2024 |
| Guggenheim | Downgraded | Buy → Neutral | — | May 15, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Mar 22, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Aug 8, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Aug 3, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Jun 5, 2023 |
Frequently asked questions
Is BOLT a buy, sell, or hold?
Analysts covering Bolt Biotherapeutics currently average a Buy rating: 3 buy, 2 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on BOLT?
On May 29, 2026, Rodman & Renshaw initiated coverage of Bolt Biotherapeutics at Buy with a price target of $22.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.